Physician profile
Karolee Fill
NPI 1407269038
$2,505.43
in general payments reported to CMS, 2019-2025
14 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $311 · 2023: $1,156 · 2024: $385 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,732 · Consulting Fee: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,732.46 |
| Consulting Fee | $218.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $809.85 | 2021-2025 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $592.53 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $353.24 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $248.92 | 2021-2025 | Farxiga, Brilinta, Lokelma |
| Impulse Dynamics (USA) INC. | $126.07 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $122.81 | 2021-2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $65.96 | 2025 | Assure Wcd |
| Abiomed | $31.99 | 2023 | Impella |
| Pfizer INC. | $30.76 | 2023 | |
| Cvrx, INC. | $29.91 | 2025 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $25.09 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.81 | 2023 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $24.34 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $19.15 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karolee Fill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.